ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,142.10
0.00%
S&P ASX All Technology
3,379.20
0.00%
Brent Oil
72.38
-1.28%
US Dollar vs AUD
1.47863
-0.01%
Bitcoin
60,456.70
0.26%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Arovella Therapeutics Ltd (ALA) Share Price

Arovella Therapeutics Ltd

Arovella Therapeutics Ltd (ALA)

Ala Spa
AltaGas Ltd
0.1575
0.00
(0.00%)
Closed 19 September 4:00PM
Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.1575
Bid
0.16
Offer
0.155
Volume
0.00
0.00 Day's Range 0.00
0.062 52 Week Range 0.185
Market Cap
165.4M
Previous Close
0.1575
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,220,418
Shares Outstanding
1,050,156,236
Dividend Yield
-
PE Ratio
-19.28
Earnings Per Share (EPS)
-0.01
Revenue
1.95M
Net Profit
-8.75M

About Arovella Therapeutics Ltd

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.sudapharma.com
Headquarters
Melbourne, Victoria, Aus
Founded
-
Arovella Therapeutics Ltd is listed in the Surgical,med Instr,apparatus sector of the Australian Stock Exchange with ticker ALA. The last closing price for Arovella Therapeutics was AUD0.16. Over the last year, Arovella Therapeutics shares have traded in a share price range of AUD 0.062 to AUD 0.185.

Arovella Therapeutics currently has 1,050,156,236 shares in issue. The market capitalisation of Arovella Therapeutics is AUD165.40 million. Arovella Therapeutics has a price to earnings ratio (PE ratio) of -19.28.

Ask ADVFN Intelligence (AI)

ALA Latest News

More News

Alcatel-Lucent Introduces New IP Routers to Extend Advanced Mobile, Business and Residential Services to Smaller Markets

New smaller scale platforms allow service providers to extend advantages of Service Routing to furthest reaches of IP network edge at a more economical price point PARIS, Oct. 28 /PRNewswire/...

29 October 2009
PR Newswire (US)

Amsterdam Public Library Selects Converged IP Solution From Alcatel-Lucent for State of the Art Voice and Data Network

PARIS, July 3 /PRNewswire-FirstCall/ -- The Amsterdam Public Library has selected Alcatel-Lucent's IP (Euronext Paris and NYSE:ALU) technology as the foundation of a comprehensive communications...

03 July 2007
PR Newswire (US)

China Unicom Selects Alcatel-Lucent IP Service Routers for Nationwide Network Transformation

PARIS, July 3 /PRNewswire-FirstCall/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced that its industry-leading IP routing solution has been selected by China Unicom, a leading...

03 July 2007
PR Newswire (US)

Alcatel-Lucent Announces Software Platform That Lets Mobile Operators Capitalize on the Increasing Demand for Mobile Content Sho

PARIS, June 13 /PRNewswire-FirstCall/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced the availability of the enhanced Alcatel-Lucent 5965 Mobile Content Platform, a powerful...

13 June 2007
PR Newswire (US)

Vodafone and Alcatel-Lucent Cooperate to Deliver 32nd America's Cup Competition Live to Mobile Users in Spain

VALENCIA, Spain, June 1 /PRNewswire-FirstCall/ -- Vodafone and Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced a cooperation agreement to deliver the award-winning America's Cup...

01 June 2007
PR Newswire (US)

Alcatel Alenia Space Signs a Euro 661 Million Contract With Globalstar to Build Their Second-Generation LEO Satellite Constellat

PARIS, December 4 /PRNewswire-FirstCall/ -- Alcatel Alenia Space today announced it has signed a Euro 661 million contract with Globalstar, Inc. (NASDAQ:GSAT), a leading provider of mobile...

05 December 2006
PR Newswire (US)

Alcatel-Lucent Signs Definitive Agreement to Acquire Nortel's UMTS Radio Access Business

Closing Expected by end of the Year PARIS, December 4 /PRNewswire-FirstCall/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) announced today that it has signed an agreement with Nortel to...

04 December 2006
PR Newswire (US)

Alcatel-Lucent Announces New Visual Identity

PARIS, December 1 /PRNewswire-FirstCall/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today unveiled the new brand mark that will represent the world's largest communications supplier. The...

01 December 2006
PR Newswire (US)

Alcatel and Lucent Complete Merger Creating World's Leading Communication Solutions Provider

PARIS and MURRAY HILL, New Jersey, November 30 /PRNewswire-FirstCall/ -- - Unparalleled Communication Solutions Leader With Global Reach, and a Local Presence in 130 Countries - A Leader in...

01 December 2006
PR Newswire (US)

Alcatel and Lucent Announce Amendment and Extension of Consent Solicitation

- Lucent's 2.75% Series A Convertible Senior Debentures due 2023 PARIS, and MURRAY HILL, N.J., Nov. 27 /PRNewswire-FirstCall/ -- Alcatel (Paris: CGEP.PA and NYSE: ALA) and Lucent Technologies...

28 November 2006
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.01258.620689655170.1450.1650.142517454640.15214289DE
40.007550.150.1650.1410221100.14742649DE
120.022516.66666666670.1350.1850.1312204180.15341964DE
260.007550.150.1850.10515681480.13366756DE
520.0815107.2368421050.0760.1850.06220072050.11951861DE
1560.1085221.4285714290.0490.1850.0219040280.07438976DE
2600.1085221.4285714290.0490.1850.0219040280.07438976DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
1ADAdAlta Limited
AUD 0.018
(0.00%)
0
14DO1414 Degrees Limited
AUD 0.008
(0.00%)
0
14DN1414 Degrees Limited
AUD 0.00
(0.00%)
0
14D1414 Degrees Limited
AUD 0.063
(0.00%)
0
13S13 Seeds Limited
 0.00
(0.00%)
0
1ADAdAlta Limited
AUD 0.018
(0.00%)
0
14DO1414 Degrees Limited
AUD 0.008
(0.00%)
0
14DN1414 Degrees Limited
AUD 0.00
(0.00%)
0
14D1414 Degrees Limited
AUD 0.063
(0.00%)
0
13S13 Seeds Limited
 0.00
(0.00%)
0
TAHTabcorp Holdings Limited
AUD 0.70
(0.00%)
1.1M
S32South32 Limited
AUD 3.151
(0.00%)
608.4k
BHPBHP Group Limited
AUD 49.94
(0.00%)
353.11k
FMGFortescue Ltd
AUD 27.00
(0.00%)
275.6k
BPTBeach Energy Limited
AUD 1.40
(0.00%)
271.4k

Discussion

View Full Feed
Dcab Dcab 3 minutes ago
Here is the website from the otc profile.

http://www.goldenvalleydevinc.com/

Has this link updated recently?
GVDI
manibiotech manibiotech 3 minutes ago
Yes
And at ASM they said they haven’t even started the process of writing the pricing model to submit for appraisal as far as I remember and no timeline was given ( unless you consider several months as a timeline )
ASM
Disquisition Disquisition 4 minutes ago
UNIMAGINABLE DELISTING DUMPING!!!!
SMFL
stockanalyze stockanalyze 4 minutes ago
lot of crazy stuff in this election. 0.5% reduction saying inflation is under control.excuse me? fries is still over $4.50 . a subway sandwich that used to be $4.00 is close to $9.00. yeah, do it as you need that fed chair position again.
FNMA
gitreal gitreal 4 minutes ago
I will accept that you are telling the truth about having the auditor confirm that they are handling BMXI's audit. But I stand by my statement that no audit will be done. The auditor may have been asked to respond that way....but normally an auditor will not answer any questions, even just to conf
BMXI
threewheeler threewheeler 5 minutes ago
$AHRO $$ The valuation analysis will be based on replacement value, future CF of the asset, and comparative market values of similar libraries.
We are monetizing the asset by virtue of our broadcasting it on Maybacks and receiving ad dollars for it. The value by either or all methods will be
AHRO
Humbert Humbert 6 minutes ago
Humbert holds for gold. 😎
BNCM
Dragonman1 Dragonman1 7 minutes ago
That's Not Why You think they need a RS, You just want the last laugh!
KEGS
JoeForkeyBolo JoeForkeyBolo 7 minutes ago
Advice from the Masters that will benefit Novavax investors.

https://investorshub.advfn.com/uimage/uploads/2024/9/18/lppdmPeter_Lynch_1_.jpg

https://investorshub.advfn.com/uimage/uploads/2024/9/18/igpzlPeter_Lynch_4.jpg

https://investorshub.advfn.com/uima
NVAX
flipper44 flipper44 7 minutes ago
No, I used commercial version, as I explained, as the commercial version of Eden, but not yet certified. You just argue to argue. Try listening.

If you started with the manual version, you’d be redundant and possibly setting up more verification transitions in the future.
NWBO
cadillacdave cadillacdave 7 minutes ago
Hardly bragging about success. It was a response to his posting of 13% gains, (buts its ok when an NVDA bull posts such gains) which is hardly a success in the bull market we have had.

Set it and forget in the S&P made 19% so far this year. So my point was that 13% is nothing to brag
NVDA
manibiotech manibiotech 7 minutes ago
They will get vote to increase the AS count
NWBO
janice shell janice shell 8 minutes ago
Apparently not.
stockanalyze stockanalyze 8 minutes ago
you are right. he spent all his time under pence's desk.
FNMA
janice shell janice shell 9 minutes ago
Sorta like what Harris is using to run on then right? In other words Harris has jack shit.

She has everything she should need. She wants to preserve our democracy. She wants to make sure Trump the wannabe Putin does n't return to office. It shouldn't be all that hard for you to see th
mouton29 mouton29 9 minutes ago
It does not make economic sense for Crown to close the buyout of RVNC without securing the US rights to Teoxane’s dermal fillers.

That may be but there is the little matter of the merger agreement that they signed. And it explicitly provides that Revance can seek specific performance
RVNC
blackhawks blackhawks 9 minutes ago
Woman with a child and not so humble, about her body, as Sarah Slanders has led us to believe she should be. 😏
lvald13 lvald13 9 minutes ago
Here is the link for fast...pretty strong company, the owner used to work for McLaren
https://fast.auto/h2h/
VVPR
Aloe18 Aloe18 9 minutes ago
😂😂😂
Tell the Feds.
VPLM
threewheeler threewheeler 10 minutes ago
AZRH yeap looks like a few flippers took some profit today
AZRH
Jayplayer Jayplayer 10 minutes ago
6:09
?
3. HUMBL Financial - Now an Avrio Co., HUMBL
Financial was built to deliver products and services for the blockchain-tokenized trading markets.
HUMBL
HUMBL Wallet
HUMBL.com
HUMBL Financial
An Avno worldwide co
HUMBL
HUMBL's
HMBL
Investor082 Investor082 10 minutes ago
What do you mean commercial version. You mean approved commercially by the notified body like the MIA human approval we received earlier this month. If so, this ain't happening for another 18-24 months at a minimum.

Either way, the answer is no. I would rather start the trial with a m
NWBO
vlispxpert vlispxpert 11 minutes ago
RELI-wasn't even trading after hours & they brought one to me, my #3 holding LOL
RELI

Your Recent History

ASX
ALA
Arovella Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved